Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Burosumab for CSHS

NCT03993821

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Children's National Hospital Washington D.C., District of Columbia, United States
View Trial Details
Completed

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

NCT01708941

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Foothills Hospital Boulder, Colorado, United States
View all 276 locations
View Trial Details
Completed

Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

NCT03405155

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Columbia University New York, United States
  • Univeristy of Pennsylvania Philadelphia, Pennsylvania, United States
  • Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

NCT06307093

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +22 more
Locations
  • State Budgetary Healthcare Institution of the city of Moscow "Moscow City Oncological Hospital No. 62 of the Department of Health of the City of Moscow" Istra, Moscow Oblast, Russia
  • "New Clinic" LLC Pyatigorsk, Stavropol Territory, Russia
  • Regional State Budgetary Healthcare Institution "Altai Regional Oncological Dispensary" Barnaul, The Altai Republic, Russia
  • Autonomous Institution of the Chuvash Republic "Republican Clinical Oncological Dispensary" of the Ministry of Health of the Chuvash Republic Cheboksary, The Chuvash Republic, Russia
View all 23 locations
View Trial Details
Completed

Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma

NCT06320353

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Federal State Budgetary Institution "National Medical Research Center of Radiology" of the Ministry of Health of the Russian Federation Obninsk, Kaluga Oblast, Russia
  • State Budgetary Healthcare Institution "Clinical Oncological Dispensary No. 1" of the Ministry of Health of the Krasnodar Territory Krasnodar, Krasnodar Territory, Russia
  • Regional Budgetary Healthcare Institution "Kursk Oncological Research and Clinical Center named after G.E. Ostroverkhov" Kislino, Kursk Oblast, Russia
  • State Budgetary Healthcare Institution of the city of Moscow "Moscow City Oncological Hospital No. 62 of the Department of Health of the City of Moscow" Istra, Moscow Oblast, Russia
View all 36 locations
View Trial Details

Related conditions